confirmed that YBX1 interacts with IGF2BP2, enhancing MYC and BCL‐2 mRNA stability and upregulating their translation in an m6A‐dependent manner, thereby promoting AML cell survival. The gene discussed is BCL2; the disease is acute myeloid leukemia.